Tenet Healthcare (NYSE:THC) Hits New 1-Year High on Better-Than-Expected Earnings

Tenet Healthcare Corporation (NYSE:THC)’s stock price hit a new 52-week high on Thursday following a stronger than expected earnings report. The company traded as high as $229.00 and last traded at $225.86, with a volume of 3392868 shares. The stock had previously closed at $193.04.

The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.05 by $0.65. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.During the same period in the previous year, the business posted $3.44 EPS. The firm’s revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

Key Stories Impacting Tenet Healthcare

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Q4 earnings beat and revenue acceleration — Tenet reported $4.70 EPS vs. consensus ~ $4.05 and revenue rose ~8.9% year‑over‑year (~$5.53B), driven by hospital and ambulatory surgery demand. Tenet Healthcare Profit Rises on Ambulatory and Hospital Revenue Growth
• Positive Sentiment: Raised/clear FY‑2026 targets and EBITDA range — Management provided 2026 EPS guidance and an adjusted‑EBITDA target ($4.485B–$4.785B), signaling confidence in continued margin expansion and cash flow. Tenet Healthcare outlines $4.485B–$4.785B 2026 adjusted EBITDA target
• Positive Sentiment: Management commentary and investor materials emphasize structural cost initiatives and M&A as levers to sustain growth and margins, reinforcing the outlook. Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
• Positive Sentiment: Market reaction — Coverage notes the stock hit record highs and traded on heavy volume after the release, indicating broad investor enthusiasm. Tenet Healthcare stock rises after Q4 beat
• Neutral Sentiment: Full‑year guidance range vs. consensus — Tenet gave an EPS range (16.19–18.47) and revenue range ($21.5B–$22.3B) that broadly brackets analyst expectations; midpoint is roughly close to consensus but leaves room for execution risk. Tenet Healthcare beats Q4 expectations, issues solid 2026 outlook
• Negative Sentiment: Earlier concerns about patient‑day trends — Pre‑earnings commentary flagged that lower hospital patient days could pressure margins if the trend extended; investors will watch operating metrics closely in coming quarters. Will Lower Patient Days Affect Tenet Healthcare’s Q4 Earnings?

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. JPMorgan Chase & Co. lifted their price target on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Guggenheim lifted their target price on Tenet Healthcare from $238.00 to $257.00 and gave the company a “buy” rating in a research note on Tuesday, December 2nd. Wells Fargo & Company reduced their price target on shares of Tenet Healthcare from $252.00 to $229.00 and set an “overweight” rating for the company in a research report on Wednesday, January 7th. Morgan Stanley reaffirmed an “overweight” rating and set a $247.00 price objective on shares of Tenet Healthcare in a research report on Thursday, December 18th. Finally, Truist Financial reiterated a “buy” rating and issued a $240.00 target price (up previously from $225.00) on shares of Tenet Healthcare in a research report on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $233.88.

Insider Activity at Tenet Healthcare

In other news, Director Nadja West sold 2,178 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the sale, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.81% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Tenet Healthcare

A number of institutional investors have recently added to or reduced their stakes in the company. Picton Mahoney Asset Management raised its holdings in Tenet Healthcare by 144.4% in the 4th quarter. Picton Mahoney Asset Management now owns 3,121 shares of the company’s stock valued at $620,000 after acquiring an additional 1,844 shares in the last quarter. Meeder Asset Management Inc. increased its position in shares of Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after purchasing an additional 114 shares during the period. Empowered Funds LLC lifted its position in Tenet Healthcare by 11.8% in the fourth quarter. Empowered Funds LLC now owns 233,204 shares of the company’s stock worth $46,342,000 after purchasing an additional 24,673 shares during the period. Janney Montgomery Scott LLC raised its stake in shares of Tenet Healthcare by 52.0% in the 4th quarter. Janney Montgomery Scott LLC now owns 21,395 shares of the company’s stock valued at $4,252,000 after buying an additional 7,315 shares in the last quarter. Finally, Deutsche Bank AG boosted its position in shares of Tenet Healthcare by 7.3% during the 4th quarter. Deutsche Bank AG now owns 161,036 shares of the company’s stock valued at $32,001,000 after acquiring an additional 10,997 shares in the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Tenet Healthcare Price Performance

The company has a quick ratio of 1.64, a current ratio of 1.71 and a debt-to-equity ratio of 2.27. The company’s 50-day moving average is $198.00 and its 200-day moving average is $193.90. The stock has a market cap of $19.85 billion, a price-to-earnings ratio of 15.48, a price-to-earnings-growth ratio of 0.82 and a beta of 1.44.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.